Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · IEX Real-Time Price · USD
4.995
-0.235 (-4.49%)
At close: Apr 17, 2024, 4:00 PM
4.910
-0.085 (-1.70%)
After-hours: Apr 17, 2024, 6:22 PM EDT
Company Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments.
The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.
Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Creative Medical Technology Holdings, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Timothy Warbington |
Contact Details
Address: 211 E. Osborn Rd. Phoenix, Arizona 85012 United States | |
| Phone | 480-399-2822 |
| Website | creativemedicaltechnology.com |
Stock Details
| Ticker Symbol | CELZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001187953 |
| CUSIP Number | 22529Y200 |
| ISIN Number | US22529Y4089 |
| Employer ID | 87-0622284 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Timothy Warbington | Co-Founder, Chairman, President and Chief Executive Officer |
| Donald Dickerson | Senior Vice President, Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 22, 2024 | 10-K | Annual Report |
| Dec 20, 2023 | 8-K | Current Report |
| Nov 14, 2023 | 10-Q | Quarterly Report |
| Nov 3, 2023 | DEF 14A | Other definitive proxy statements |
| Aug 11, 2023 | 10-Q | Quarterly Report |
| Jun 28, 2023 | 8-K | Current Report |
| Jun 9, 2023 | 8-K | Current Report |
| May 26, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| May 12, 2023 | 10-Q | Quarterly Report |
| May 2, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |